IRD - Opus Genetics, Inc.
0.7599
0.026 3.369%
Share volume: 165,602
Last Updated: 04-23-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.73
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-12-2024 | |
| Cash flow financing | 2.376 M | 1.540 M | 353.000 K | |
| Other financing cash flows | -42.000 K | 0.000 | 0.000 | |
| Cash flow | -3.340 M | 0.000 | 0.000 | |
| Net income | -7.106 M | -7.765 M | -7.526 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | -3.340 M | -5.752 M | -4.777 M |
